FLORAL
Long-term treatment with etavopivat in people with sickle cell disorder or thalassaemia https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/7822-floral-long-term-treatment-with-etavopivat-in-people-with-sickle-cell-disease-or-thalassaemia/
REDRESS (RElated haplo-DonoR haematopoietic stEm cell transplantation for adults with Severe Sickle cell disease)
The purpose of this trial is to determine whether stem cell transplant using haplo-identical related donors is safe, effective, and cost worthy in treating people with sickle cell disorder compared […]
NIHR Rapid Service Evaluation Team (REVAL)
Evaluation of pilot hyperacute units to deliver acute sickle cell care as part of a wider programme of quality improvement (SCD)In response to recognition of avoidable deaths and failures of […]
INSCHOOL
The INSCHOOL project is a 5 year National Institute for Health and Care Research (NIHR) funded research programme looking at the school lives of young people (11-18) living with long-term […]
Improving Black Health Outcomes (IBHO) BioResource
The IBHO BioResource is a new research programme from the NIHR BioResource in collaboration with King’s College London and Genomics England, focused on improving our knowledge and understanding of health […]
HIBISCUS
Exploring the use of a new drug in patients with sickle cell disease. The HIBISCUS study started at the King’s College Hospital Denmark Hill campus in June 2022 with patients […]
Haematology Lived Experience and Outcomes (HALO)
HALO is a research study looking at the survival rates of people diagnosed with Sickle Cell Disorder or Beta Thalassemia, acute Lymphoblastic or acute Myeloid Leukaemia in childhood and the long-term effects of that diagnosis and treatment.